Astrazeneca AZN Cash Flow Statement (2009-2026)

NYSE AZN
$183.91 -2.85 (-1.53%)
As of: Nov 11, 2026 · 10:36 AM EST
Reported Financials

Astrazeneca Quarterly Cash Flow Statement

Periods 71 quarters
Latest Sep 2026

Astrazeneca reported cash from operations of $4.67B and free cash flow of $7.96B for the quarter ended Sep 2026, down 9.1% year over year. This cash flow statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-346.00M388.00M360.00M1,642.00M902.00M1,804.00M1,820.00M1,378.00M959.00M2,180.00M1,928.00M1,433.00M1,500.00M2,921.00M2,448.00M2,535.00M2,329.00M3,081.00M2,508.00M3,116.00M
Depreciation, Depletion & Amortization
AmortizationAmort.
Depreciation & Amortization (CF)Dep. & Amort.
2,192.00M1,309.00M1,357.00M1,502.00M1,276.00M1,255.00M1,279.00M1,817.00M2,337.00M1,284.00M1,389.00M1,549.00M1,511.00M1,366.00M1,929.00M1,605.00M
Share-based CompensationStock Comp.
Gains from Equity InvestmentsGains Equity
1.00M-1.00M-6.00M-10.00M-10.00M
Gains from Sales and DivestituresGains Divest
-513.00M-10.00M-71.00M-104.00M-249.00M-251.00M-13.00M-64.00M-66.00M-21.00M-31.00M105.00M-34.00M-94.00M-28.00M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
Cash from Restructuring
Other non-cash itemsOther Non-Cash
95.00M-327.00M125.00M-692.00M-429.00M489.00M-386.00M-674.00M769.00M-80.00M-121.00M31.00M909.00M-349.00M743.00M-253.00M713.00M-585.00M
Change in Working Capital
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
Other Operating Activities (as filed)
Cash from OperationsCash from Ops.
1,418.00M3,232.00M1,248.00M3,133.00M1,718.00M2,486.00M3,085.00M3,383.00M2,907.00M3,713.00M3,386.00M5,134.00M2,342.00M3,359.00M2,865.00M4,666.00M
Investing Activities
Capital ExpendituresCapex
1,859.00M-219.00M691.00M-247.00M764.00M-417.00M1,216.00M-2,015.00M3,140.00M-429.00M1,517.00M-2,862.00M4,584.00M-547.00M1,857.00M-3,296.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
3.00M125.00M1.00M53.00M2.00M1.00M9.00M3.00M8.00M4.00M1.00M
Change in Property, Plant and EquipmentChange in PP&E
-1,856.00M219.00M-691.00M372.00M-763.00M470.00M-1,216.00M2,015.00M-3,138.00M430.00M-1,508.00M2,862.00M-4,581.00M555.00M-1,853.00M3,297.00M
Change in IntangiblesChange Intangibless
1,823.00M-144.00M578.00M-1,223.00M2,659.00M-1,188.00M2,662.00M-3,889.00M5,077.00M-540.00M2,344.00M-4,648.00M5,939.00M-991.00M4,324.00M-7,195.00M
Acquisitions
-189.00M378.00M-726.00M3,497.00M-5,542.00M-6.00M
Net of Acquisitions & DivestmentsNet Acquisitions
189.00M-378.00M726.00M-3,497.00M5,542.00M6.00M
Purchase of InvestmentsInvestments Purchased
-776.00M
Sale and Maturity of InvestmentsInvestments Sold
8.00M5.00M
Other Investing Activities (as filed)Other investing (as filed)
514.00M3.00M465.00M67.00M429.00M93.00M214.00M-26.00M197.00M67.00M83.00M63.00M111.00M67.00M174.00M-60.00M
Cash from Investing ActivitiesCash from Investing
-913.00M-168.00M-800.00M-1,246.00M-520.00M-2,413.00M-2,872.00M-1,514.00M-1,181.00M-1,253.00M-2,108.00M-2,001.00M-1,446.00M-1,792.00M-2,912.00M-1,885.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
7,693.00M-4.00M1,261.00M-2,004.00M5,412.00M-7.00M2,650.00M-7,290.00M9,299.00M-4.00M20.00M-36.00M2,049.00M-2.00M2,455.00M-4,909.00M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-7,693.00M4.00M-1,261.00M2,004.00M-5,412.00M7.00M-2,650.00M7,290.00M-9,299.00M4.00M-20.00M36.00M-2,049.00M2.00M-2,455.00M4,909.00M
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-7,693.00M4.00M-1,261.00M2,004.00M-5,412.00M7.00M-2,650.00M7,290.00M-9,299.00M4.00M-20.00M36.00M-2,049.00M2.00M-2,455.00M4,909.00M
Change in Capital Stock
Common Stock IssuedStock Issued
19.00M5.00M3.00M4.00M4.00M6.00M5.00M4.00M23.00M8.00M4.00M5.00M23.00M10.00M6.00M4.00M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
19.00M5.00M3.00M4.00M4.00M6.00M5.00M4.00M23.00M8.00M4.00M5.00M23.00M10.00M6.00M4.00M
Net Equity Issued and RepurchasedNet Equity Issued
19.00M5.00M3.00M4.00M4.00M6.00M5.00M4.00M23.00M8.00M4.00M5.00M23.00M10.00M6.00M4.00M
Dividend Payments
Dividends Paid - Common and PreferredDiv Paid (Total)
7,712.00M-2,971.00M5,942.00M-3,047.00M6,116.00M-3,033.00M6,083.00M-7,676.00M9,255.00M-3,347.00M6,704.00M-8,325.00M9,939.00M-3,287.00M6,575.00M-8,243.00M
Other financing activities (as filed)
-404.00M301.00M-435.00M97.00M-226.00M1,001.00M-1,151.00M722.00M-888.00M1,099.00M-1,285.00M1,568.00M-1,937.00M2,334.00M-2,516.00M1,632.00M
Cash from Financing ActivitiesCash from Financing
-5,095.00M3,064.00M-8,099.00M6,848.00M1,887.00M-5,437.00M6,281.00M73.00M733.00M1,349.00M3,881.00M2,460.00M-4,649.00M9,060.00M-14,415.00M1,567.00M-3,892.00M6,626.00M
Additional items
Exchange Rate EffectFX Effect
11.00M-9.00M-26.00M-11.00M-36.00M-46.00M-6.00M20.00M-61.00M25.00M29.00M-12.00M4.00M-18.00M9.00M-7.00M
Change in Cash
-546.00M-676.00M-847.00M-144.00M-321.00M2,101.00M-1,009.00M-2,262.00M1,055.00M-247.00M1,796.00M1,060.00M-2,386.00M1,834.00M-2,639.00M3,040.00M
Beginning Cash Balance
Ending Cash Balance
6,038.00M5,762.00M4,817.00M5,983.00M6,232.00M5,664.00M5,637.00M7,841.00M6,916.00M4,797.00M5,429.00M5,230.00M7,032.00M8,143.00M5,698.00M7,560.00M4,884.00M7,936.00M
Free Cash FlowFCF
-441.00M3,451.00M557.00M3,380.00M954.00M2,903.00M1,869.00M5,398.00M-233.00M4,142.00M1,869.00M7,996.00M-2,242.00M3,906.00M1,008.00M7,962.00M
Net Cash FlowNCF
-4,590.00M6,128.00M-7,651.00M6,848.00M3,774.00M-4,239.00M6,281.00M146.00M946.00M3,218.00M5,607.00M4,920.00M-3,371.00M12,193.00M-13,519.00M3,134.00M-3,939.00M9,407.00M
Interest Paid
-721.00M-194.00M580.00M-849.00M-257.00M740.00M-1,081.00M-341.00M924.00M-1,658.00M-1,313.00M-422.00M1,045.00M-1,692.00M2,385.00M-441.00M1,071.00M-1,777.00M
Income Taxes PaidTaxes Paid
-1,743.00M-228.00M1,234.00M-1,623.00M-225.00M1,286.00M-2,366.00M-430.00M1,767.00M-3,315.00M-2,750.00M-363.00M1,912.00M-3,742.00M5,038.00M-526.00M2,577.00M-4,685.00M

Astrazeneca Cash Flow Statement API

Pull Astrazeneca's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AZN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY